N. Segretti

Synthetic Strategies toward SGLT2 Inhibitors

Anderson R. Aguillón, Alessandra Mascarello, N. Segretti et al. · Organic Process Research & Development · 2018 · 83 citations

Medicinal Chemistry, Synthetic Strategies, Diabetes Management +15

New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors

N. Segretti, Ricardo A. M. Serafim, Mariana C. F. Segretti et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 33 citations · Full text

New Antibacterial Agents, Antimicrobial Drug Discovery, Medicine +10

Discovery of <b>ACH-000143</b>: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats

Marcos Antonio Ferreira, Hátylas Azevedo, Alessandra Mascarello et al. · Journal of Medicinal Chemistry · 2021 · 11 citations · Full text

Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis

N. Segretti, Cristina Kortstee Simões, Michelle Fidelis Corrêa et al. · Tuberculosis · 2016 · 10 citations · Full text